Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma
Molecular Therapy: Oncology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001827?dgcid=rss_sd_all
Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001827?dgcid=rss_sd_all
“Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.” Molecular Therapy: Oncology.
@article{article94767,
title = {Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001827?dgcid=rss_sd_all}
}